Professor Moshe Many to leave post as Vice Chairman effective January 1, 2014, will remain a member of the board
Amir Elstein to succeed Professor Moshe Many...
10 December 2013 | By Teva
Amir Elstein to succeed Professor Moshe Many...
List view / Grid view
Amir Elstein to succeed Professor Moshe Many...
10 December 2013 | By Teva
Amir Elstein to succeed Professor Moshe Many...
Dr. Jeremy Levin will step down as President and Chief…
30 October 2013 | By Teva Pharmaceutical Industries Ltd
Dr. Jeremy Levin will step down as President and Chief Executive Officer...
Teva announced that Dr. Arie Belldegrun was appointed by the…
11 February 2013 | By Teva Pharmaceutical Industries Ltd
Teva announced that Dr. Arie Belldegrun was appointed by the Board of Directors...
“Dr. Phillip Frost has the Board’s full support..."
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb,…
1 January 2012 | By Teva
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...